Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inflammatory process affecting an artery.
Biomarker and diagnostic research for arteritis has been reported in the published literature.
81 clinical trials registered, 50 recruiting. Interventions under study include other interventions, drug therapy, biologic therapy, and medical devices. Pipeline includes 10 PHASE4, 8 PHASE3, 6 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05388682](https://clinicaltrials.gov/study/NCT05388682) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:00 AM UTC
Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement |
— |
Chinese Pulmonary Vascular Disease Research Group |
RECRUITING |
[NCT03372980](https://clinicaltrials.gov/study/NCT03372980) | A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA) | — | Beijing Institute of Heart, Lung and Blood Vessel Diseases | RECRUITING |
[NCT05904301](https://clinicaltrials.gov/study/NCT05904301) | Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases | — | Santé Arménie French-Armenian Research Center | RECRUITING |
[NCT04300686](https://clinicaltrials.gov/study/NCT04300686) | A Pilot Study in Severe Patients With Takayasu Arteritis. | PHASE4 | Shanghai Zhongshan Hospital | RECRUITING |
[NCT05437965](https://clinicaltrials.gov/study/NCT05437965) | National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis | — | China National Center for Cardiovascular Diseases | RECRUITING |
347 publications have been identified in PubMed for arteritis. Kisho has analyzed 273 by research type. Research spans Review / Meta-Analysis (36%), Case Report / Case Series (22%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 99 | 36% |
Patient case studies | 59 | 22% |
Testing and diagnosis research | 35 | 13% |
Disease patterns and progression | 31 | 11% |
Clinical study results | 21 | 8% |
Laboratory research | 15 | 5% |
Other research | 8 | 3% |
New treatment approaches | 5 | 2% |
Feltgen N (2026). [PMID: 41702552](https://pubmed.ncbi.nlm.nih.gov/41702552/). *Klin Monbl Augenheilkd*. [Review / Meta-Analysis]
Yao S (2026). [PMID: 41556275](https://pubmed.ncbi.nlm.nih.gov/41556275/). *Vasc Endovascular Surg*. [Case Report / Case Series]
Reisch M (2026). [PMID: 42081084](https://pubmed.ncbi.nlm.nih.gov/42081084/). *Drugs*. [Review / Meta-Analysis]
Mew A (2026). [PMID: 41771038](https://pubmed.ncbi.nlm.nih.gov/41771038/). *Clin Nucl Med*. [Case Report / Case Series]
Schmidt WA (2026). [PMID: 41923480](https://pubmed.ncbi.nlm.nih.gov/41923480/). *Expert Opin Pharmacother*. [Review / Meta-Analysis]
Luo Y (2026). [PMID: 41442262](https://pubmed.ncbi.nlm.nih.gov/41442262/). *European journal of clinical investigation*. [Case Report / Case Series]
Beirão TMBDM (2026). [PMID: 41524215](https://pubmed.ncbi.nlm.nih.gov/41524215/). *J Clin Rheumatol*. [Review / Meta-Analysis]
Chapron L (2026). [PMID: 41570312](https://pubmed.ncbi.nlm.nih.gov/41570312/). *Retina*. [Basic Science / Preclinical]
Benichou A (2026). [PMID: 42276733](https://pubmed.ncbi.nlm.nih.gov/42276733/). *RMD Open*. [Epidemiology / Natural History]
Bukun HO (2026). [PMID: 41653289](https://pubmed.ncbi.nlm.nih.gov/41653289/). *Rheumatol Int*. [Epidemiology / Natural History]